Literature DB >> 25649111

Commentary on Hey and Kimmelman.

Donald A Berry1.   

Abstract

Mesh：

Year:  2015        PMID： 25649111     DOI： 10.1177/1740774515569011

Source DB:  PubMed          Journal:  Clin Trials        ISSN： 1740-7745            Impact factor:   2.486


× No keyword cloud information.
  6 in total

1.  A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma.

Authors:  Vinay K Puduvalli; Jing Wu; Ying Yuan; Terri S Armstrong; Elizabeth Vera; Jimin Wu; Jihong Xu; Pierre Giglio; Howard Colman; Tobias Walbert; Jeffrey Raizer; Morris D Groves; David Tran; Fabio Iwamoto; Nicholas Avgeropoulos; Nina Paleologos; Karen Fink; David Peereboom; Marc Chamberlain; Ryan Merrell; Marta Penas Prado; W K Alfred Yung; Mark R Gilbert
Journal:  Neuro Oncol       Date:  2020-10-14       Impact factor: 12.300

2.  Adaptive Clinical Trials: Advantages and Disadvantages of Various Adaptive Design Elements.

Authors:  Edward L Korn; Boris Freidlin
Journal:  J Natl Cancer Inst       Date:  2017-06-01       Impact factor: 13.506

3.  A post hoc evaluation of a sample size re-estimation in the Secondary Prevention of Small Subcortical Strokes study.

Authors:  Leslie A McClure; Jeff M Szychowski; Oscar Benavente; Robert G Hart; Christopher S Coffey
Journal:  Clin Trials       Date:  2016-04-19       Impact factor: 2.486

4.  Using Adaptive Designs to Avoid Selecting the Wrong Arms in Multiarm Comparative Effectiveness Trials.

Authors:  Byron J Gajewski; Jeffrey Statland; Richard Barohn
Journal:  Stat Biopharm Res       Date:  2019-06-26       Impact factor: 1.452

5.  Clinical trialist perspectives on the ethics of adaptive clinical trials: a mixed-methods analysis.

Authors:  Laurie J Legocki; William J Meurer; Shirley Frederiksen; Roger J Lewis; Valerie L Durkalski; Donald A Berry; William G Barsan; Michael D Fetters
Journal:  BMC Med Ethics       Date:  2015-05-03       Impact factor: 2.652

Review 6.  Interim analysis: A rational approach of decision making in clinical trial.

Authors:  Amal Kumar; Bhaswat S Chakraborty
Journal:  J Adv Pharm Technol Res       Date:  2016 Oct-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.